Anti-IL-13RA2 Antibody-FITC (9B615)

Name: Anti-IL-13RA2 Antibody-FITC (9B615)
Brand: TargetMol
SKU: TMAY-00669F
Rating: 4.5 (1 reviews)

(Synonyms: interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2) Copy Product Info

🥰Excellent

Synonyms: interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2

Catalog No. TMAY-00669F Copy Product Info

🥰Excellent

Anti-IL-13RA2 Antibody-FITC (9B615) is a FITC-conjugated Rabbit antibody targeting IL-13RA2. Anti-IL-13RA2 Antibody-FITC (9B615) can be used in FCM.

Anti-IL-13RA2 Antibody-FITC
(9B615)

Pack Size	Price	USA Stock	Global Stock	Quantity
25 T	$104	7-10 days	7-10 days
100 T	$327	7-10 days	7-10 days

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Resource Download

Instruction Manual of Detection Antibody

Product Introduction

Bioactivity

Description	Anti-IL-13RA2 Antibody-FITC (9B615) is a FITC-conjugated Rabbit antibody targeting IL-13RA2. Anti-IL-13RA2 Antibody-FITC (9B615) can be used in FCM.
Synonyms	interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2
Ig Type	Rabbit IgG
Clone	9B615
Reactivity	Human
Specificity	Human IL-13 R alpha 2/IL13RA2

Application	FCM
Recommended Dose	10 μl/Test, 0.1 mg/ml
Antibody Type	Monoclonal
Host Species	Rabbit
Construction	This antibody was obtained from a rabbit immunized with purified, recombinant Human IL13RA2 / CD213A2 (rh IL13RA2 / CD213A2; TMPY-00841; NP_000631.1; Met1-Leu342) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
Purification	Protein A
Appearance	Liquid
Formulation	PBS solution containing 0.5% BSA and 0.03%ProClin300
Research Background	Interleukin-13 receptor subunit alpha-2 (IL13RA2/IL-13RA2) is also known as cluster of differentiation 213A2 (CD213A2), IL-13 receptor subunit alpha-2, IL-13R subunit alpha-2, and IL-13RA2. The IL13RA2 is often overexpressed in brain tumors, making Il13ra2 one of the vaccine targets for immunotherapy of glioma. IL13RA2/IL-13RA2 is a cancer-associated receptor that is present in greater than 80% of High-Grade Astrocytomas (HGA) and has recently been recognized as a cytokine that predisposes breast cancer cells to metastasize. Expression of IL13Rα2 was rapidly lost from the surface of transduced cells grown in culture. The loss appeared to be related to ligands present in fetal bovine serum in the medium. None of the malignant glioma cell lines cultivated in vitro and tested to date exhibited the IL13Rα2 receptor. A recombinant virus (R5111) enters cells via its interaction with the IL13Rα2 receptor in a manner that cannot be differentiated from the interaction of wild-type virus with its receptors.